INTENT-Muscle (A Sub-study of INTENT)

计划入组 21 人 · 首次发布于 2021 年 5 月 21 日

Multi-omics to Predict Responses to Biologics in IBD

计划入组 1,050 人 · 首次发布于 2022 年 9 月 15 日

A Clinical Study to Evaluate the Efficacy of Biologics in SpA

计划入组 40 人 · 首次发布于 2020 年 5 月 22 日

Purified Exosome Product (Rion)

QBSAU

QBECP

Rion Inc.

South Korea

GENSIGHT BIOLOGICS

France

BlueWillow Biologics

South Korea

RION Spins Out INTENT Biologics to Advance Exosome-Based Therapies for Inflammation and Immunology

Extracellular Vesicles as Next-Generation Therapeutics: Global Pipeline, Regulatory Landscape, and Translational Challenges

INTENT Biologics Receives FDA Fast Track Designation for First-in-Class Exosome Therapy for Diabetic Foot Ulcers